Early in his career, he developed methodologies for the production of therapeutic agents on a large scale. Working for a pharmaceutical company, he was in charge of a development unit that transferred ideas and procedures from the research lab into the manufacture of antibiotics, steroids and enzymes in large quantities.
At the University of Michigan, he turned his attention to the more medical aspects of research, and soon began working on understanding how certain tissues, particularly those in the kidney, separate toxic materials from blood. His research led him to develop an ideal artificial membrane that sorts molecules by size, allowing researchers to understand how tissues sort molecules and also to design membranes for use in devices such as the artificial kidney.
Schultz became interested, too, in how biological cells select nutrients while preventing harmful chemicals from gaining access to the cells' interior. His research on carrier-mediated transport helped pave the way for industry to develop liquid membranes for purification processes.
He received his bachelor's and master's degrees in chemical engineering at Columbia University, and his doctorate in biochemistry from the University of Wisconsin.
The author or coauthor of more than 120 research papers, he has edited six books and holds several patents. He has been editor-in-chief of the journal Biotechnology Progress for 20 years, and serves on the editorial boards of several other scientific journals.
He is a founding member and past president of the American Institute for Medical and Biological Engineering, which serves and coordinates a broad constituency of medical and biological scientists and practitioners, bioengineering societies, bioengineering departments and biomedical industries.
A member of the National Academy of Engineering
|Contact: Iqbal Pittalwala|
University of California - Riverside